Problem Solving Methods of US and EU Pharmaceutical Companies

Read also

• Pharmaceutical Consulting

  Custom Intelligence Biosimilars Report

  You’ve probably noticed that biosimilars are the growth engine in global medicine spending right now. You’re not alone. With biologics accounting for 20-22% of total pharmaceutical spending already and looking to grow to $320 bn in the US alone by 2023, more and more companies and looking to compete in this arena. Informa’s Biosimilars Insights and Analysis Service can bring you the market intelligence and insights to inform your decisions and help ensure you’re not missing out on opportunities.

  Topics Biosimilars

  Single Report

• Pharmaceutical Consulting

  Custom Intelligence Biosimilars Whitepaper

  If you’re looking at the opportunities to increase revenue and mitigate current and future threats by formulating the strongest biosimilars strategy, Informa’s Biosimilars Insights and Analysis Service is the tool you need.

  Topics Biosimilars

  View white paper